Thank you EuropaBio - the European Association for Bioindustries and Claire Skentelbery for organizing today’s webinar and interesting panel discussion focusing on the impact of the #EU’s General Pharma Legislation on Europe’s innovation ecosystem. While Europe has a strong scientific base, European investment in innovation is falling behind other regions. It is important for innovators to have strong predictability of IP incentives, reducing baseline incentives will reduce investment in Europe, especially in the rare disease area and the need to develop novel technologies! Also, thank you Wojciech Nowak, MA, IMD EMBA for highlighting that despite #EU’s historical strengths, we need to consider global dynamics (in particular having a look at #clinicaltrials) when it comes to the future role of Europe in the global innovation ecosystem next to US and China. We need legislation that empowers innovation, gives certainty to innovators and allows Europe to be an attractive launch market. #innovation #rarediseases #noveltherapies #bioetchecosystem
Join us tomorrow for a presentation of our latest study by Charles River Associates, followed by a panel discussion featuring leading voices of the European biotechnology ecosystem. See the agenda below! 🗓️ When: Thursday, March 7, 2024, from 13:00 to 14:30 CET. 📍 Where: Online, via Zoom webinar. ℹ️ More information & Registration: https://lnkd.in/e642gZrz Claire Skentelbery | Antun Sablek | John Ricketts | Noel Minnis | Thomas Bols | Tineke Van hooland | Wojciech Nowak, MA, IMD EMBA | Yordan Aleksandrov #biotechinnovation #biotech #healthcare #ecosystem
Thank you very much for the kind words, we are working all together for the future of European biotech.